Paul Tudor Jones Fiveprime Therapeutics Inc Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
N/A
-20,030 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
N/A
-4,325 Reduced 17.76%
20,030 $94,000
Q2 2020

Aug 14, 2020
SELL
N/A
-36,794 Reduced 60.17%
24,355 $149,000
Q1 2020

May 15, 2020
SELL
N/A
-29,455 Reduced 32.51%
61,149 $139,000
Q4 2019

Feb 14, 2020
SELL
N/A
-1,063 Reduced 1.16%
90,604 $416,000
Q3 2019

Nov 14, 2019
BUY
N/A
1,800 Added 2.0%
91,667 $355,000
Q2 2019

Aug 14, 2019
BUY
N/A
89,867 New
89,867 $542,000
Q4 2018

Feb 14, 2019
SELL
N/A
-16,199 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
N/A
16,199 New
16,199 $225,000
Q1 2018

May 15, 2018
SELL
N/A
-16,496 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
N/A
6,363 Added 62.79%
16,496 $362,000
Q3 2017

Nov 14, 2017
BUY
N/A
10,133
10,133 $415,000
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email